Kim Tzoumakas has been named the new CEO of Plano-based pharmacy services company Maxor National Pharmacy Services, which simultaneously announced a “strategic combination” with pharmacy management firm ProxsysRx.
Tzoumakas succeeds Mike Ellis, who has retired as chief executive officer and moved into the role of board chairman after leading the company since 2016. Maxor said Tzoumakas has been appointed to the board of directors as well.
Tzoumakas is a seasoned executive with more than 25 years of strategic and operational leadership experience within the healthcare sector, Maxor said. Most recently, she was CEO of RAYUS Radiology, a national provider of advanced diagnostic and interventional radiology services.
“Founded almost 100 years ago, Maxor has built a strong reputation over many decades for excellence in pharmacy care, with a unique set of capabilities that drive significant value for its clients,” Tzoumakas said in a statement. “I am honored to have the opportunity to succeed Mike Ellis and lead the organization into its next phase of growth, and I couldn’t be more excited about the tremendous opportunity ahead of us.”
Combining Maxor and Alabama-based PrxsysRX will accelerate the growth of Maxor’s Pharmacy Services segment and position Maxor as the largest independent provider of pharmacy management services to health systems, hospitals, clinics, and other provider organizations, the company said.
‘A shared commitment to innovation’
Maxor said that hospital and health system clients of both Maxor and ProxsysRx now will have a full spectrum of pharmacy management solutions in one pharmacy services organization, with end-to-end capabilities across specialty and retail pharmacy management, 340B optimization, and manufacturer and payer support services.
“ProxsysRx combining with Maxor marks an exciting step forward in our focus on delivering comprehensive and integrated pharmacy care solutions to our health system and provider clients,” Tzoumakas said. “In growing our Pharmacy Services business with the addition of ProxsysRx, we are bringing new and expanded solutions to our partners that deliver both clinical and financial value.”
Maxor said that along with PBM solutions delivered via MaxorPlus, clients now will be able to fully integrate their pharmacy service lines with their pharmacy benefit strategies to improve patient access, affordability and outcomes while mitigating annual benefit cost increases.
“I’m incredibly excited about this new chapter with Maxor,” ProxsysRx CEO George Salem said in a statement. “Our organizations have a shared commitment to innovation and delivering exceptional client service and patient care. In joining forces with Maxor, we can bring new capabilities and resources to serve our clients in expanded ways.”
Salem will transition to a board observer role with Maxor while working closely with Tzoumakas and the Maxor leadership team.
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.
R E A D N E X T
-
Irving-Based McKesson Launches Project To Address 'Pharmacy Deserts' in Underserved U.S. CommunitiesLow-income residents without access to vehicles often find themselves more than a mile from much-needed medicines and prescription drugs. Project Oasis, a new McKesson initiative, aims to help address that.
-
Qualthera, a new company founded by entrepreneur Donald Prentiss, has made its first acquisition—Central Drug in Victoria, Texas—and set its sights on Dallas for its second. Prentiss sees an opportunity in the shifting pharmacy landscape, where changes, including downsizing by large chains, have created service gaps that independent pharmacies could fill.
-
Premature babies diagnosed with bronchopulmonary dysplasia (BPD) face the risk of rehospitalization, delayed brain development, and respiratory problems throughout childhood. No FDA-approved therapies are available for BPD—which is why the new FDA designation for AyuVis's drug candidate, AVR-48, could lead to game-changing impact.
-
The museum, currently being built in Fort Worth's Historic Southside neighborhood, has a $70 million fundraising goal and is slated to open in 2025. The 50,000-square-foot Juneteenth Museum center will also host guest lectures, community events, and performances in its 250-seat amphitheater, while offering a food hall, store fronts, and a business incubator to boost local entrepreneurship.
-
As part of a nationwide effort, the NFEC chose Texas as one of its initial launch states because of the demonstrated need for greater economic empowerment among Texans.
